These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17942782)

  • 1. Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
    Warady BA; Seligman PA; Dahl NV
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1140-6. PubMed ID: 17942782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
    Baribeault D
    Curr Med Res Opin; 2011 Aug; 27(8):1653-7. PubMed ID: 21714710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects.
    Seligman PA; Dahl NV; Strobos J; Kimko HC; Schleicher RB; Jones M; Ducharme MP
    Pharmacotherapy; 2004 May; 24(5):574-83. PubMed ID: 15162891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
    Yorgin PD; Belson A; Sarwal M; Alexander SR
    Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients.
    Zanen AL; Adriaansen HJ; van Bommel EF; Posthuma R; Th de Jong GM
    Nephrol Dial Transplant; 1996 May; 11(5):820-4. PubMed ID: 8671901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
    J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron supplementation in adolescent hemodialysis patients.
    Nailescu C; Castaneda M; Del Rio M; Flynn JT
    Clin Nephrol; 2004 Dec; 62(6):449-54. PubMed ID: 15630904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron indices after administration of sodium ferric gluconate complex in hemodialysis patients.
    Shalansky K; Hanko J; Pudek M; Li G; Jastrzebski J
    Am J Kidney Dis; 2011 Oct; 58(4):684-5. PubMed ID: 21840100
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly administration of high-dose sodium ferric gluconate is safe and effective in peritoneal dialysis patients.
    Javier AM
    Nephrol Nurs J; 2002 Apr; 29(2):183-6. PubMed ID: 11997953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
    Kaskel FJ
    Nat Clin Pract Nephrol; 2006 May; 2(5):244-5. PubMed ID: 16932433
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of ferumoxytol versus sodium ferric gluconate in anemia management in outpatient hemodialysis patients: A prospective cohort study.
    El Nekidy WS; El-Masri MM; Kadri A; Soong DC
    Clin Nephrol; 2021 Apr; 95(4):189-194. PubMed ID: 33433318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation.
    Scheiber-Mojdehkar B; Lutzky B; Schaufler R; Sturm B; Goldenberg H
    J Am Soc Nephrol; 2004 Jun; 15(6):1648-55. PubMed ID: 15153577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin saturation with intravenous irons: an in vitro study.
    Agarwal R
    Kidney Int; 2004 Sep; 66(3):1139-44. PubMed ID: 15327409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis.
    Warady BA; Zobrist RH; Finan E;
    Pediatr Nephrol; 2006 Apr; 21(4):553-60. PubMed ID: 16520948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers.
    Danielson BG; Salmonson T; Derendorf H; Geisser P
    Arzneimittelforschung; 1996 Jun; 46(6):615-21. PubMed ID: 8767353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.